Latest News

30 May 2014 New Guidelines for Planning and Developing Cancer Registries in Low- and Middle-Income Settings Cancer prevention
28 May 2014 European Medicines Agency Adopted a Change to an Indication for Eribulin Anticancer agents & Biologic therapy
27 May 2014 European Medicines Agency Recommends to Extend Indications for Ofatumumab Haematologic malignancies - Anticancer agents & Biologic therapy
26 May 2014 European Medicines Agency Recommends to Refuse a Change to the Marketing Authorisation for Bevacizumab Central nervous system malignancies - Anticancer agents & Biologic therapy
23 May 2014 ESMO Press Release: ESMO, UICC, NCD Alliance and Other Endorsing Partners Issue Palliative Care Statement at WHA
23 May 2014 European Medicines Agency Recommends Granting a Marketing Authorisation for Obinutuzumab Haematologic malignancies - Anticancer agents & Biologic therapy
21 May 2014 Study Calls for Revisiting Cardiac Screening Guidelines for Survivors of Childhood Cancer Cancer in Special Situations
01 Sep 2014 Image of the Month
20 May 2014 A Mathematical Biologist Against Cancer Translational research - Central nervous system malignancies - Lung and other thoracic tumours
19 May 2014 New Science of Toxgnostics Personalised medicine - Anticancer agents & Biologic therapy
Ovarian Cancer
13 May 2014 Hypertension Related to VEGF Inhibitors Anticancer agents & Biologic therapy